HUAPONT LIFE SCIENCES CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.44 CNY | +0.91% |
|
-0.67% | -4.72% |
| Sales 2021 | 12.36B 1.71B | Sales 2022 | 13.23B 1.83B | Capitalization | 10.1B 1.39B |
|---|---|---|---|---|---|
| Net income 2021 | 670M 92.56M | Net income 2022 | 433M 59.82M | EV / Sales 2021 | 1.4 x |
| Net Debt 2021 | 2.95B 407M | Net Debt 2022 | 2.36B 325M | EV / Sales 2022 | 0.94 x |
| P/E ratio 2021 |
21.3
x | P/E ratio 2022 |
23.3
x | Employees | 12,476 |
| Yield 2021 |
3.04% | Yield 2022 |
4.31% | Free-Float | 63.24% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.91% | ||
| 1 week | -0.67% | ||
| Current month | +2.78% | ||
| 1 month | +1.37% | ||
| 3 months | +2.07% | ||
| 6 months | -6.53% | ||
| Current year | -4.72% |
1 week
4.37
4.55
1 month
4.214.57
Current year
3.784.74
1 year
3.785.46
3 years
3.789.80
5 years
3.789.80
10 years
3.7820.04
| Managers | Title | Age | Since |
|---|---|---|---|
Hai An Zhang
CEO | Chief Executive Officer | 43 | 18-09-30 |
Jian Wang
DFI | Director of Finance/CFO | 48 | 14-01-09 |
Yun Hui Peng
BRD | Director/Board Member | 60 | 01-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Song Shan Zhang
CHM | Chairman | 63 | 01-08-31 |
Yun Hui Peng
BRD | Director/Board Member | 60 | 01-08-31 |
Zhong Hai Liu
BRD | Director/Board Member | 49 | 21-08-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 31 M€ | +2.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 4.44 | +0.91% | 12,257,200 |
| 24-04-24 | 4.4 | -0.68% | 10,149,930 |
| 24-04-23 | 4.43 | -1.56% | 11,451,600 |
| 24-04-22 | 4.5 | -0.44% | 13,423,660 |
| 24-04-19 | 4.52 | +1.35% | 13,116,180 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
HUAPONT LIFE SCIENCES CO., LTD. is a China-based company principally engaged in the research and development, manufacture and sales of pesticide chemical products. The Company operates through three segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sales of skin pharmaceuticals, antituberculous pharmaceuticals and other manufactured products. Its products include fleroxacin and ambroxol hydrochloride for injection, and lecithin-bound iodine capsules, among others. The Pesticide Chemical segment is engaged in the production and sales of pesticides and other fine chemicals, including herbicides, bactericides and insecticides, among others. The Bulk Drug segment is engaged in the research and development and manufacture of bulk drugs and medical intermediates. The Company is also engaged in the provision of travel services, the sales of tea and the provision of technical services, among others.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -4.72% | 1.2B | |
| +24.17% | 562B | |
| -6.33% | 358B | |
| +19.90% | 322B | |
| +7.95% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -12.26% | 149B | |
| -6.47% | 146B |
- Stock Market
- Equities
- 002004 Stock
